- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 7/50 - Cyclic peptides containing at least one abnormal peptide link
Patent holdings for IPC class C07K 7/50
Total number of patents in this class: 306
10-year publication summary
|
22
|
18
|
32
|
24
|
16
|
18
|
33
|
13
|
20
|
11
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Protagonist Therapeutics, Inc. | 138 |
16 |
| Ohio State Innovation Foundation | 2058 |
9 |
| Fog Pharmaceuticals, Inc. | 14 |
8 |
| Centre National de La Recherche Scientifique | 10227 |
7 |
| The University of Tokyo | 4111 |
7 |
| Chugai Seiyaku Kabushiki Kaisha | 1322 |
6 |
| Bicyclerd Limited | 142 |
6 |
| Bristol-myers Squibb Company | 4848 |
5 |
| Merck Sharp & Dohme Corp. | 2202 |
4 |
| Aileron Therapeutics, Inc. | 80 |
4 |
| Dana-Farber Cancer Institute, Inc. | 2531 |
4 |
| Napp Pharmaceutical Group Limited | 21 |
4 |
| Peptidream Inc. | 74 |
4 |
| University of Rochester | 1300 |
4 |
| Merck Sharp & Dohme LLC | 3728 |
4 |
| Apellis Pharmaceuticals, Inc. | 120 |
3 |
| DSM Sinochem Pharmaceuticals Netherlands B.V. | 60 |
3 |
| Fundacion para La Investigacion Medica Aplicada | 61 |
3 |
| Invectys | 35 |
3 |
| Osaka University | 3332 |
3 |
| Other owners | 199 |